BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2341178)

  • 1. Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.
    Iwase M; Lally ET; Berthold P; Korchak HM; Taichman NS
    Infect Immun; 1990 Jun; 58(6):1782-8. PubMed ID: 2341178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells.
    Taichman NS; Iwase M; Lally ET; Shattil SJ; Cunningham ME; Korchak HM
    J Immunol; 1991 Nov; 147(10):3587-94. PubMed ID: 1940358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.
    DiRienzo JM; Tsai CC; Shenker BJ; Taichman NS; Lally ET
    Infect Immun; 1985 Jan; 47(1):31-6. PubMed ID: 3965404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line.
    Zambon JJ; DeLuca C; Slots J; Genco RJ
    Infect Immun; 1983 Apr; 40(1):205-12. PubMed ID: 6572616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
    Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
    Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin.
    Simpson DL; Berthold P; Taichman NS
    Infect Immun; 1988 May; 56(5):1162-6. PubMed ID: 3258584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans.
    Johansson A; Claesson R; Hänström L; Sandström G; Kalfas S
    J Periodontal Res; 2000 Apr; 35(2):85-92. PubMed ID: 10863962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Actinobacillus actinomycetemcomitans outer membrane vesicles with HL60 cells does not require leukotoxin.
    Demuth DR; James D; Kowashi Y; Kato S
    Cell Microbiol; 2003 Feb; 5(2):111-21. PubMed ID: 12580947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes.
    Mangan DF; Taichman NS; Lally ET; Wahl SM
    Infect Immun; 1991 Sep; 59(9):3267-72. PubMed ID: 1879940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.
    Taichman NS; Iwase M; Korchak H; Berthold P; Lally ET
    J Periodontal Res; 1991 May; 26(3 Pt 2):258-60. PubMed ID: 1831848
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Actinobacillus actinomycetemcomitans leukotoxin with nucleic acids on the bacterial cell surface.
    Ohta H; Hara H; Fukui K; Kurihara H; Murayama Y; Kato K
    Infect Immun; 1993 Nov; 61(11):4878-84. PubMed ID: 8406888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.
    Kolodrubetz D; Dailey T; Ebersole J; Kraig E
    Infect Immun; 1989 May; 57(5):1465-9. PubMed ID: 2707855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
    Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
    Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative inactivation of Actinobacillus actinomycetemcomitans leukotoxin by the neutrophil myeloperoxidase system.
    Clark RA; Leidal KG; Taichman NS
    Infect Immun; 1986 Aug; 53(2):252-6. PubMed ID: 3015798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
    Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
    Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora.
    Johansson A; Hänström L; Kalfas S
    Oral Microbiol Immunol; 2000 Aug; 15(4):218-25. PubMed ID: 11154406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity.
    Johansson A; Sandström G; Claesson R; Hänström L; Kalfas S
    Eur J Oral Sci; 2000 Apr; 108(2):136-46. PubMed ID: 10768727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipids inhibit cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human polymorphonuclear leukocytes.
    Ginsburg I; Tsai CC; Wrenn SM; Taichman NS
    Inflammation; 1982 Dec; 6(4):365-70. PubMed ID: 7160873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic antibodies to the leukotoxin of the oral pathogen Actinobacillus actinomycetemcomitans correlate negatively with stroke in women.
    Johansson A; Johansson I; Eriksson M; Ahrén AM; Hallmans G; Stegmayr B
    Cerebrovasc Dis; 2005; 20(4):226-32. PubMed ID: 16123541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of lipoprotein-dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils.
    Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Kalfas S
    APMIS; 2002 Dec; 110(12):857-62. PubMed ID: 12645663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.